NCT06575127View on ClinicalTrials.gov

Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study

PHASE2RecruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

August 17, 2024

Primary Completion Date

September 1, 2025

Study Completion Date

September 1, 2026

Conditions

Neoplasm MalignantColon Cancer Stage 4

Interventions

DRUG

FOLFOXIRI Protocol

as mentioned in Arm description

Trial Locations (1)

11311

RECRUITING

Al Hussien University Hospital, Cairo

All Listed Sponsors

lead

Al-Azhar University

OTHER